108 research outputs found

    Resonant-Frequency Discharge in a Multi-Cell Radio Frequency Cavity

    Get PDF
    We are reporting experimental results on a microwave discharge operating at resonant frequency in a multi-cell radio frequency (RF) accelerator cavity. Although the discharge operated at room temperature, the setup was constructed so that it could be used for plasma generation and processing in fully assembled active superconducting radio-frequency cryo-module. This discharge offers a mechanism for removal of a variety of contaminants, organic or oxide layers, and residual particulates from the interior surface of RF cavities through the interaction of plasma-generated radicals with the cavity walls. We describe resonant RF breakdown conditions and address the issues related to resonant detuning due to sustained multi-cell cavity plasma. We have determined breakdown conditions in the cavity, which was acting as a plasma vessel with distorted cylindrical geometry. We discuss the spectroscopic data taken during plasma removal of contaminants and use them to evaluate plasma parameters, characterize the process, and estimate the volatile contaminant product removal

    High Power Test of RF Separator for 12 GEV Upgrade of CEBAF at Jefferson Lab

    Get PDF
    CEBAF at JLab is in the process of an energy upgrade from 6 GeV to 12 GeV. The existing setup of the RF separator cavities in the 5th pass will not be adequate enough to extract the highest energy (11 GeV) beam to any two existing halls (A, B or C) while simultaneously delivering to the new hall D in the case of the proposed 12 GeV upgrade of the machine. To restore this capability, several options including the extension of existing normal conducting (NC) and a potential 499 MHz TEM-type superconducting (SC) cavity design have been investigated using computer simulations. Detailed numerical studies suggest that six 2-cell normal conducting structures meet the requirements; each 2-cell structure will require up to 4 kW RF input power in contrast with the current nominal operating power of 1.0 to 2.0 kW. A high power test to 4 kW is required to confirm the cavity’s operate-ability at these elevated gradient and power levels. We have assembled a 2-cell cavity, pumped down to 2.0·10-9 torr using ion pump and confirmed the low level RF performance. A high power test is in progress and will be completed soon. The detailed numerical and experimental results will be discussed in the paper

    Status of Superconducting RF Linac Development for APT

    Get PDF
    This paper describes the development progress of high current superconducting RF linacs in Los Alamos, performed to support a design of the linac for the APT (Accelerator Production of Tritium) Project. The APT linac design includes a CW superconducting RF high energy section, spanning an energy range of 211 to 1030 MeV, and operating at a frequency of 700 MHz with two constant beta sections (beta of 0.64 and 0.82). In the last two years, we have progressed towards build a cryomodule with beta of 0.64. We completed the designs of the 5 cell superconducting cavities and the 210 kW power couplers. We are scheduled to begin assembly of the cryomodule in September 2000. In this paper, we present an overview of the status of our development efforts and a report on the results of the cavity and coupler test program.Comment: LINAC2000 THD1

    Cryomodule development for the CEBAF upgrade

    Full text link
    Long term plans for CEBAF at Jefferson Lab call for achieving 12 GeV in the middle of the next decade and 24 GeV after 2010. In support of these plans, an Upgrade Cryomodule capable of providing more than three times the voltage of the original CEBAF cryomodule specification within the same length is under development. Development activities have been focused on critical areas thought to have maximum impact on the overall design. These have included the cavity structure, rf power coupling, cavity suspension, alignment, cavity tuning, and beamline interface. It has been found that all design and development areas are tightly coupled and can not be developed independently. Substantial progress has been made toward an integrated design for the Jefferson Lab Upgraded Cryomodule

    The increase in pulmonary arterial pressure caused by hypoxia depends on iron status

    Get PDF
    Hypoxia is a major cause of pulmonary hypertension. Gene expression activated by the transcription factor hypoxia-inducible factor (HIF) is central to this process. The oxygen-sensing iron-dependent dioxygenase enzymes that regulate HIF are highly sensitive to varying iron availability. It is unknown whether iron similarly influences the pulmonary vasculature. This human physiology study aimed to determine whether varying iron availability affects pulmonary arterial pressure and the pulmonary vascular response to hypoxia, as predicted biochemically by the role of HIF. In a controlled crossover study, 16 healthy iron-replete volunteers undertook two separate protocols. The ‘Iron Protocol’ studied the effects of an intravenous infusion of iron on the pulmonary vascular response to 8 h of sustained hypoxia. The ‘Desferrioxamine Protocol’ examined the effects of an 8 h intravenous infusion of the iron chelator desferrioxamine on the pulmonary circulation. Primary outcome measures were pulmonary artery systolic pressure (PASP) and the PASP response to acute hypoxia (ΔPASP), assessed by Doppler echocardiography. In the Iron Protocol, infusion of iron abolished or greatly reduced both the elevation in baseline PASP (P < 0.001) and the enhanced sensitivity of the pulmonary vasculature to acute hypoxia (P = 0.002) that are induced by exposure to sustained hypoxia. In the Desferrioxamine Protocol, desferrioxamine significantly elevated both PASP (P < 0.001) and ΔPASP (P = 0.01). We conclude that iron availability modifies pulmonary arterial pressure and pulmonary vascular responses to hypoxia. Further research should investigate the potential for therapeutic manipulation of iron status in the management of hypoxic pulmonary hypertensive disease

    Noninvasive assessment of asthma severity using pulse oximeter plethysmograph estimate of pulsus paradoxus physiology

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Pulsus paradoxus estimated by dynamic change in area under the oximeter plethysmograph waveform (PEP) might provide a measure of acute asthma severity. Our primary objective was to determine how well PEP correlates with forced expiratory volume in 1-second (%FEV<sub>1</sub>) (criterion validity) and change of %FEV<sub>1 </sub>(responsiveness) during treatment in pediatric patients with acute asthma exacerbations.</p> <p>Methods</p> <p>We prospectively studied subjects 5 to 17 years of age with asthma exacerbations. PEP, %FEV<sub>1</sub>, airway resistance and accessory muscle use were recorded at baseline and at 2 and 4 hours after initiation of corticosteroid and bronchodilator treatments. Statistical associations were tested with Pearson or Spearman rank correlations, logistic regression using generalized estimating equations, or Wilcoxon rank sum tests.</p> <p>Results</p> <p>We studied 219 subjects (median age 9 years; male 62%; African-American 56%). Correlation of PEP with %FEV<sub>1 </sub>demonstrated criterion validity (r = - 0.44, 95% confidence interval [CI], - 0.56 to - 0.30) and responsiveness at 2 hours (r = - 0.31, 95% CI, - 0.50 to - 0.09) and 4 hours (r = - 0.38, 95% CI, - 0.62 to - 0.07). PEP also correlated with airway resistance at baseline (r = 0.28 for ages 5 to 10; r = 0.45 for ages 10 to 17), but not with change over time. PEP was associated with accessory muscle use (OR 1.16, 95% CI, 1.11 to 1.21, P < 0.0001).</p> <p>Conclusions</p> <p>PEP demonstrates criterion validity and responsiveness in correlations with %FEV<sub>1</sub>. PEP correlates with airway resistance at baseline and is associated with accessory muscle use at baseline and at 2 and 4 hours after initiation of treatment. Incorporation of this technology into contemporary pulse oximeters may provide clinicians improved parameters with which to make clinical assessments of asthma severity and response to treatment, particularly in patients who cannot perform spirometry because of young age or severity of illness. It might also allow for earlier recognition and improved management of other disorders leading to elevated pulsus paradoxus.</p
    corecore